PF-06700841 + Itraconazole
Phase 1Completed 0 watching 0 views this week💤 Quiet
32
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Heathy Participants
Conditions
Heathy Participants
Trial Timeline
Sep 24, 2019 → Dec 19, 2019
NCT ID
NCT04090047About PF-06700841 + Itraconazole
PF-06700841 + Itraconazole is a phase 1 stage product being developed by Pfizer for Heathy Participants. The current trial status is completed. This product is registered under clinical trial identifier NCT04090047. Target conditions include Heathy Participants.
Hype Score Breakdown
Clinical
10
Activity
5
Company
9
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04090047 | Phase 1 | Completed |
Competing Products
4 competing products in Heathy Participants
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| AZD7053 + Placebo | AstraZeneca | Phase 1 | 33 |
| Ticagrelor 90 mg whole tablet + Ticagrelor 90 mg tablet crushed + Dispersed ticagrelor 90 mg tablet suspended in water - nasogastric tube | AstraZeneca | Phase 1 | 33 |
| Treatment A (BDA MDI HFO) + Treatment B (BDA MDI HFA) | AstraZeneca | Phase 1 | 33 |
| Immune Globulin (Human) | Grifols | Approved | 82 |